1[1]Wright AL, Holberg C J, Martinez FD. Epidemiology of physician-diagnosed allergic rhinitis in childhood[ J ]. Pediatrics, 1994, 94(6 Pt 1):895-901.
2[2]Mygind N, Dahl R. The rationale for use of topical corticosteroids in allergic rhinitis[J]. Clin Exp Allergy, 1996, 26( Suppl 3): 2 - 10.
3[3]Baraniuk JN, Meltzer EO, Spector SL. Putting together an effective plan for managing allergic rhinitis [ J]. J Respir Dis, 1996, 17(Suppl 8):S34-S44.
4[4]Spector SL. Allergic and nonallergic rhinitis: update on pathophysiology and clinical management [ J ]. Am J Ther,1995, 2(2) :290- 295.
5[5]Yap YG, Camm AJ. The current cardiac safety situation with antihistamines[ J] . Clin Exp Allergy, 1999, 29(Suppl 1):15-24.
6[6]Nolen TM. Sedative effects of antihistamines: safety, performance, learning, and quality of life [ J ]. Clin Ther,1997, 19(1): 39 - 55.
7[7]Mattila MJ, Paakkari I. Variations among non-sedating antihistamines: are there real differences[ J] ? Eur J Clin Pharmacol, 1999, 55(2):85-93.
8[8]Gonzalez MA, Estes KS. Pharmacokinetic overview of oral second-generation H1 antihistamines[J]. Int J Clin Pharmacol Ther, 1998, 36(5) :292 - 300.
9[9]Simpson K, Jarvis B. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria[J]. Drugs, 2000, 59(2) :301 - 321.
10[10]Spector SL. Overview of comorbid associations of allergic rhinitis[J]. J Allergy Clin Immunol, 1997; 99(2) :S773 -S780.
